NanoLogix Inc (NNLX)

[capitalismforever]

"A rough analysis of the economic potential of the NanoLogix N-Assay technology is offered at the end of this post. The result is astounding and involves only the assumption that this technology can capture a 20 percent share of the US Group B Strep test market."

Nanologix represents less than 1% of the companies competing for market share of Group B Strep but the above analysis assumes they'll capture 20% of the total Group B Strep market? That is highly illogical in my opinion especially since they haven't even captured a percent of the market thusfar and the product hasn't even been approved for commercial use. The poorly thought out analysis has counted the chickens before they've hatched.

My analysis isn't based on assumptions, nor highly illogical ones. It is based on what is actually occurring and what has occurred.